![]() |
市場調查報告書
商品編碼
1734846
低溫運輸包裝冷媒市場預測(至 2032 年):按類型、包裝類型、應用、最終用戶和地區進行的全球分析Cold Chain Packaging Refrigerants Market Forecasts to 2032 - Global Analysis By Type (Gel Packs, Ice Packs, Dry Ice, Liquid Nitrogen, Phase Change Materials, Eutectic Plates, and Other Types), Packaging Type, Application, End Users and By Geography |
根據 Stratistics MRC 的數據,全球低溫運輸包裝冷媒市場預計在 2025 年達到 17.2 億美元,到 2032 年將達到 33.8 億美元,預測期內的複合年成長率為 10.1%。
低溫運輸包裝冷媒是用於在運輸和儲存對溫度敏感的產品(例如藥品、生技藥品和易生鮮食品)過程中保持低溫的專用材料。這些冷媒可以是凝膠包、乾冰或相變材料,透過防止溫度波動來幫助維持產品完整性。它們是低溫運輸物流的重要組成部分,確保符合法規要求,並在受控溫度條件下最大限度地減少遠距或長期運輸過程中的損壞。
根據 Pelican 的 2020 年生物製藥低溫運輸物流永續性研究,約有 38% 的生物製藥公司使用可重複使用的租賃貨櫃,其中 25% 的公司考慮在 2019 年這樣做。
對溫度敏感藥品的需求不斷增加
製藥業越來越依賴低溫運輸包裝冷媒來維持對溫度敏感的藥物的功效。隨著疫苗、生技藥品和特種藥物需求的不斷成長,保持嚴格的溫度控制對於防止劣化至關重要。先進的冷卻技術確保了安全的運輸和儲存,從而支持了生技藥品和個人化藥物的成長。政府強制執行的嚴格溫度維持法規進一步推動了市場需求。醫藥供應鏈的擴張,尤其是在新興國家,正在推動有效冷凍解決方案的採用。
監理合規的複雜性
嚴格的法律規範規範著對溫度敏感的醫藥產品的運輸和儲存,這給製造商帶來了合規挑戰。企業必須遵守美國食品藥物管理局 (FDA) 和世界衛生組織 (WHO) 等組織制定的嚴格全球標準,通常需要大量的文件和檢驗。適應不同地區的法規會增加業務的複雜性,並影響物流和供應鏈的效率。違規可能導致產品召回、法律後果和財務損失,從而阻礙市場成長。
電子商務和線上雜貨服務的全球擴張
消費者擴大訂購生鮮產品,例如冷凍食品、乳製品和生鮮食品,這需要在運輸過程中提供有效的冷卻解決方案。零售商和物流供應商正在採用先進的冷媒,以確保最後一哩配送過程中的產品品質和安全。直接面對消費者的藥品運輸量的增加進一步推動了醫療物流中冷媒的應用。包裝材料和冷媒的技術進步為電子商務的全球擴張提供了永續、高效的冷卻方法。
供應鏈中斷和溫度異常
運輸延誤、勞動力短缺和地緣政治緊張局勢使溫控運輸面臨風險,導致產品損失。不當冷卻或不可預見的環境條件導致的溫度升高,威脅藥品和生鮮產品的品質。原料成本和能源消耗的上升也對冷媒市場的穩定性構成挑戰。企業必須投資強大的監控系統和預測分析,以降低這些風險並確保合規性。
COVID-19的影響
新冠疫情對低溫運輸包裝冷媒市場產生了重大影響,重塑了物流和供應鏈的優先事項。全球疫苗的緊急推廣推動了對高效冷媒解決方案的需求,以維持藥品在運輸過程中的穩定性。供應鏈中斷,包括勞動力短缺和物流限制,影響了冷媒的供應和定價。疫情過後,對遠端醫療和藥品直送服務的依賴度不斷提高,持續推動需求成長。
凝膠包市場預計將成為預測期內最大的市場
凝膠包因其多功能性和高效的保溫性能,預計將在預測期內佔據最大的市場佔有率。凝膠包可為藥品、食品和生物樣本提供穩定的冷卻,使其成為低溫運輸物流的首選。其易用性和再生性提高了永續性,並降低了整體包裝成本。相變材料的進步進一步提升了凝膠包的性能,最佳化了冷卻時間和穩定性。
預計診斷實驗室部門在預測期內將以最高的複合年成長率成長。
由於對溫度敏感診斷材料的需求不斷成長,預計診斷實驗室領域將在預測期內實現最高成長。血液樣本、試劑和檢測套組需要嚴格的溫度控制,以在運輸過程中保持其完整性。感染疾病的爆發和診斷技術的進步刺激了對專用冰袋解決方案的需求。全球實驗室網路和醫療檢測設施的擴張進一步推動了市場的成長。
由於製藥和食品行業的快速擴張,預計亞太地區將在預測期內佔據最大的市場佔有率。中國、印度和日本等國家正大力投資低溫運輸基礎設施,以滿足日益成長的醫療保健和零售需求。消費者對新鮮和冷凍食品的偏好日益成長,推動了高效製冷解決方案的普及。政府法規要求對藥品進行嚴格的溫度控制,這將進一步推動市場成長。
預計北美地區在預測期內將實現最高的複合年成長率,這得益於該地區先進的醫療保健和食品供應鏈基礎設施。嚴格的藥品儲存和運輸法規正在推動冷媒的廣泛應用。冷媒材料和監控系統的技術創新正在提高低溫運輸的效率和可靠性。不斷擴張的電商業務,尤其是在食品雜貨和藥品配送領域的電商業務,正在推動市場成長。
According to Stratistics MRC, the Global Cold Chain Packaging Refrigerants Market is accounted for $1.72 billion in 2025 and is expected to reach $3.38 billion by 2032 growing at a CAGR of 10.1% during the forecast period. Cold chain packaging refrigerants are specialized materials used to maintain low temperatures during the transportation and storage of temperature-sensitive products, such as pharmaceuticals, biologics, and perishable foods. These refrigerants-such as gel packs, dry ice, and phase change materials-help preserve product integrity by preventing temperature fluctuations. They are critical components of cold chain logistics, ensuring regulatory compliance and minimizing spoilage during long-distance or extended-duration shipments under controlled thermal conditions.
According to Pelican's 2020 Biopharma Cold Chain Logistics Sustainability Survey, around 38% of biopharma companies had used reusable rental containers, while 25% explored them in 2019.
Rising demand for temperature-sensitive pharmaceuticals
The pharmaceutical industry increasingly relies on cold chain packaging refrigerants to preserve the efficacy of temperature-sensitive medications. With rising demand for vaccines, biologics, and specialty drugs, maintaining strict temperature controls is critical for preventing degradation. Advanced refrigerant technologies ensure safe transport and storage, supporting the growth of biologics and personalized medicine. Government regulations enforcing stringent temperature maintenance further drive the market demand. The expansion of pharmaceutical supply chains, particularly in emerging economies, fuels adoption of effective refrigerant solutions.
Complexity of regulatory compliance
Strict regulatory frameworks govern the transportation and storage of temperature-sensitive pharmaceuticals, creating compliance challenges for manufacturers. Companies must adhere to stringent global standards set by organizations such as the FDA and WHO, which often require significant documentation and validation. Meeting diverse regional regulations increases operational complexity, impacting logistics and supply chain efficiency. Non-compliance can lead to product recalls, legal consequences, and financial losses, deterring market growth.
Global expansion of e-commerce and online grocery services
Consumers increasingly order perishable goods, including frozen foods, dairy, and fresh produce, necessitating effective cooling solutions during transportation. Retailers and logistics providers are incorporating advanced refrigerants to ensure product quality and safety in last-mile deliveries. The growth of direct-to-consumer pharmaceutical shipments further amplifies refrigerant adoption across healthcare logistics. Technological advancements in packaging materials and refrigerants support sustainable and efficient cooling methods for global e-commerce expansion.
Supply chain disruptions and temperature excursions
Transportation delays, labor shortages, and geopolitical tensions can compromise temperature-controlled shipments, leading to product losses. Temperature excursions caused by inadequate cooling or unexpected environmental conditions pose threats to pharmaceutical and perishable goods quality. Rising costs of raw materials and energy consumption also challenge refrigerant market stability. Companies must invest in robust monitoring systems and predictive analytics to mitigate these risks and ensure regulatory compliance.
Covid-19 Impact
The COVID-19 pandemic significantly influenced the Cold Chain Packaging Refrigerants Market, reshaping logistics and supply chain priorities. The urgent global vaccine rollout heightened demand for efficient refrigerant solutions to preserve pharmaceutical stability during transportation. Supply chain disruptions, including labour shortages and logistics constraints, affected refrigerant availability and pricing. Post-pandemic, the growing reliance on telemedicine and direct-to-consumer pharmaceutical deliveries continues to drive demand.
The gel packs segment is expected to be the largest during the forecast period
The gel packs segment is expected to account for the largest market share during the forecast period, due to its versatility and efficiency in temperature maintenance. Gel packs offer consistent cooling for pharmaceuticals, food products, and biological samples, making them a preferred choice in cold chain logistics. Their ease of use and reusability enhance sustainability and reduce overall packaging costs. Advances in phase change materials have further improved gel pack performance, optimizing cooling duration and stability.
The diagnostic laboratories segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the diagnostic laboratories segment is predicted to witness the highest growth rate, due to the increasing demand for temperature-sensitive diagnostic materials. Blood samples, reagents, and testing kits require strict temperature control to maintain their integrity during transportation. Rising prevalence of infectious diseases and advancements in diagnostic technologies fuel demand for specialized refrigerant solutions. The expansion of laboratory networks and healthcare testing facilities worldwide further drives market growth.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to the rapid expansion of pharmaceutical and food industries. Countries like China, India, and Japan are investing heavily in cold chain infrastructure to support growing healthcare and retail demands. Increasing consumer preference for fresh and frozen food products drives widespread adoption of efficient refrigerant solutions. Government regulations mandating stringent temperature maintenance for pharmaceuticals further propel market growth.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the region's advanced healthcare and food supply chain infrastructure. Stringent regulations governing pharmaceutical storage and transportation drive significant refrigerant adoption. Technological innovations in refrigerant materials and monitoring systems enhance cold chain efficiency and reliability. Expanding e-commerce operations, particularly in grocery and pharmaceutical delivery sectors, fuel market growth.
Key players in the market
Some of the key players profiled in the Cold Chain Packaging Refrigerants Market include Cold Chain Technologies, Peli BioThermal, Sonoco ThermoSafe, Nordic Cold Chain Solutions, Cryopak, CSafe, Softbox Systems, Sealed Air Corporation, Intelsius, Sofrigam, Tempack, Orora Group, Chill-Pak, Coolpac, and Blowkings.
In December 2024, Sonoco Products Company announced it has entered into an agreement to sell its Thermoformed and Flexibles Packaging business ("TFP") to TOPPAN Holdings Inc. ("Toppan") for approximately $1.8 billion on a cash-free and debt-free basis and subject to customary adjustments (the "Transaction").
In March 2025, Cold Chain Technologies (CCT) has acquired Global Cold Chain Solutions, expanding its Asia Pacific presence & capabilities. Cold Chain Technologies ("CCT") and digital monitoring solutions for the transportation of temperature-sensitive life sciences products, today announced it has acquired Global Cold Chain Solutions ("GCCS"), a leading provider of passive cold chain solutions primarily in Australia and India. Terms of the transaction were not disclosed.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.